Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: CD45dimCD34+CD38CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia

Fig. 2

The CD45dimCD34+CD38CD133+ cells are highly expressed in the bone marrow of patients with AML, but not in healthy controls. Bone marrow cells from healthy controls and AML patients were examined for the expression of the target antigens, CD45dimCD34+CD38CD133+ cells. Data represent mean ± SEM representing three independent experiments from different AML patients. Significantly different from the control (*); ***, P < 0.001. HC, healthy controls; AML, acute myeloid leukemia patients

Back to article page